ArticlePloS one2026
Impact of coexisting diabetes on the development of cardiovascular disease and death in patients with cancer.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of the Relationship of Glycated Hemoglobin with Subclinical Atherosclerosis and Arterial Stiffness in Non-Diabetic Patients: A Retrospective Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a risk factor for the development of cardiovascular disease (CVD); however, its effects on the incidence of CVD and survival in patients with cancer without CVD at the time of cancer diagnosis remain unclear. Population-based information was obtained from the Osaka Cancer Registry linked to administrative data, and the impact of diabetes at cancer diagnosis on overall survival and the development of CVD in patients without CVD at cancer diagnosis was analyzed using Cox proportional hazards models. A total of 121,997 patients diagnosed with cancer but without CVD in Osaka Prefecture, Japan, between 2010 and 2015 were included in the analysis. Of these, 4,317 patients had diabetes at the time of cancer diagnosis. The presence of coexisting diabetes was associated with increased risks of all-cause mortality (adjusted hazard ratio: 1.40 [95% confidence interval: 1.33-1.48]) and development of CVD (1.37 [1.28-1.46]), compared with the absence of coexisting diabetes. For 21,292 patients with a record of hospitalization within 2 months prior to death, the estimated cause of death was tabulated. In all, 899 (4.6%) and 111 (6.9%) patients in the no-coexistent diabetes and coexistent diabetes groups, respectively, died from circulatory disease. In patients with cancer without CVD at cancer diagnosis, coexisting diabetes may increase the risk of developing CVD and affect survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.